SHA:688373 Revenue

In the year 2025, Shanghai MicuRx Pharmaceutical had annual revenue of 141.77M CNY with 8.83% growth. Shanghai MicuRx Pharmaceutical had revenue of 37.79M in the quarter ending December 31, 2025, with 15.52% growth.

Revenue

141.77M

Revenue Growth

+8.83%

P/S Ratio

28.56

Revenue / Employee

754.11K

Employees

177

Market Cap

4.05B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.77M	11.50M	8.83%
Dec 31, 2024	130.27M	39.50M	43.51%
Dec 31, 2023	90.78M	42.57M	88.31%
Dec 31, 2022	48.21M	40.55M	529.33%
Dec 31, 2021	7.66M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shandong Wohua Pharmaceutical	816.95M
Henan Taloph Pharmaceutical Stock Co.,Ltd	1.79B
Honz Pharmaceutical	435.39M
Qianjiang Yongan Pharmaceutical	797.25M
Tibet AIM Pharm.	628.02M
Huaren Pharmaceutical	1.26B
Zhejiang Starry Pharmaceutical	2.39B
Harbin Medisan Pharmaceutical	874.60M

Revenue Rankings